[RGLS] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
07-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 8.72%
YoY- 27.83%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 5,000 18 18 18 18 10,860 4,219 2.86%
PBT -1,315 -4,893 -8,502 -14,506 -20,015 -7,222 -22,168 -37.52%
Tax 7 -131 61 -58 5 4 -1 -
NP -1,322 -4,893 -8,563 -14,448 -20,020 -7,226 -22,168 -37.46%
Tax Rate - - - - - - - -
Total Cost 6,322 4,911 8,581 14,466 20,038 18,086 26,387 -21.17%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -26.44 -27,183.33 -47,572.22 -80,266.67 -111,222.22 -66.54 -525.43 -39.21%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.28 -2.34 -9.75 -16.68 -45.39 -16.52 -56.76 -58.70%
EPS Diluted -0.28 -2.34 -9.75 -16.68 -45.39 -16.52 -56.76 -58.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.